US-headquartered New England Biolabs (NEB), a world leader in the production of reagents for the life science industry, has extended its global subsidiary network with the opening of New England Biolabs Korea Ltd (NEB Korea).

The Republic of Korea is emerging as a global leader in the life science space, as a result of strong public sector support and private sector investments. NEB has supported researchers in South Korea for many years through its distribution network. NEB Korea will now bring a higher level of service to valued customers and local distributors in this important market.

"This new subsidiary office will provide the scientific research community in South Korea with more efficient access to the latest NEB products and technical support in the local time zone, as well as custom partnership opportunities," said Elin Yoon, Country Manager for NEB Korea. 

"It's been encouraging to see the rapid growth of South Korea's life science industry over the past few years, which is a testament to the country's relentless focus on laying the groundwork for new technologies and advancements," stated Carole Keating, Executive Director of International Business at NEB. "The expansion of our subsidiary network enables NEB to offer even greater personalised service to our customers, rapid delivery, and the ability to explore higher levels of collaboration."

NEB also maintains subsidiary offices in Australia, Canada, China, France, Germany, Japan, New Zealand, Singapore and the United Kingdom.